Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems.
Mirzaei S, Mahabady MK, Zabolian A, Abbaspour A, Fallahzadeh P, Noori M, Hashemi F, Hushmandi K, Daneshi S, Kumar AP, Aref AR, Samarghandian S, Makvandi P, Khan H, Hamblin MR, Ashrafizadeh M, Zarrabi A. Mirzaei S, et al. Among authors: daneshi s. Life Sci. 2021 Jun 15;275:119368. doi: 10.1016/j.lfs.2021.119368. Epub 2021 Mar 16. Life Sci. 2021. PMID: 33741417 Review.
C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors.
Ashrafizadeh M, Zarabi A, Hushmandi K, Moghadam ER, Hashemi F, Daneshi S, Hashemi F, Tavakol S, Mohammadinejad R, Najafi M, Dudha N, Garg M. Ashrafizadeh M, et al. Among authors: daneshi s. Curr Cancer Drug Targets. 2021;21(1):2-20. doi: 10.2174/1568009620666201016121005. Curr Cancer Drug Targets. 2021. PMID: 33069197 Review.
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities.
Ashrafizadeh M, Mirzaei S, Hashemi F, Zarrabi A, Zabolian A, Saleki H, Sharifzadeh SO, Soleymani L, Daneshi S, Hushmandi K, Khan H, Kumar AP, Aref AR, Samarghandian S. Ashrafizadeh M, et al. Among authors: daneshi s. Biomed Pharmacother. 2021 Sep;141:111824. doi: 10.1016/j.biopha.2021.111824. Epub 2021 Jun 25. Biomed Pharmacother. 2021. PMID: 34175815 Free article. Review.
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance.
Ashrafizadeh M, Saebfar H, Gholami MH, Hushmandi K, Zabolian A, Bikarannejad P, Hashemi M, Daneshi S, Mirzaei S, Sharifi E, Kumar AP, Khan H, Heydari Sheikh Hossein H, Vosough M, Rabiee N, Kumar Thakur V, Makvandi P, Mishra YK, Tay FR, Wang Y, Zarrabi A, Orive G, Mostafavi E. Ashrafizadeh M, et al. Among authors: daneshi s. Expert Opin Drug Deliv. 2022 Apr;19(4):355-382. doi: 10.1080/17425247.2022.2041598. Epub 2022 Apr 3. Expert Opin Drug Deliv. 2022. PMID: 35152815
LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions.
Entezari M, Taheriazam A, Orouei S, Fallah S, Sanaei A, Hejazi ES, Kakavand A, Rezaei S, Heidari H, Behroozaghdam M, Daneshi S, Salimimoghadam S, Mirzaei S, Hashemi M, Samarghandian S. Entezari M, et al. Among authors: daneshi s. Biomed Pharmacother. 2022 Oct;154:113609. doi: 10.1016/j.biopha.2022.113609. Epub 2022 Aug 27. Biomed Pharmacother. 2022. PMID: 36037786 Free article. Review.
40 results